Taken together, we established and characterized the GIST T-R subline lacking secondary c-KIT and PDGFRA mutations typical for the IM-resistant phenotype and exhibiting resistance to IM due to the RTK switch (c-KIT/c-MET and FGFR2α). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.